These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22086127)

  • 21. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer.
    Hu W; Zhang Y; Jiang Z; Wang L; Li J; Chen S; Dai N; Si J
    Tumour Biol; 2016 Aug; 37(8):11523-33. PubMed ID: 27086036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells.
    Ashley RA; Dubuque SH; Dvorak B; Woodward SS; Williams SK; Kling PJ
    Pediatr Res; 2002 Apr; 51(4):472-8. PubMed ID: 11919332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human erythropoietin attenuates neuronal apoptosis and cognitive defects via JAK2/STAT3 signaling in experimental endotoxemia.
    Zhou TF; Yu JG
    J Surg Res; 2013 Jul; 183(1):304-12. PubMed ID: 23236988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin promotes retinal angiogenesis in a mouse model.
    Wen CT; He T; Xing YQ
    Mol Med Rep; 2014 Dec; 10(6):2979-84. PubMed ID: 25269825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietin and small molecule agonists of the tissue-protective erythropoietin receptor increase FXN expression in neuronal cells in vitro and in Fxn-deficient KIKO mice in vivo.
    Miller JL; Rai M; Frigon NL; Pandolfo M; Punnonen J; Spencer JR
    Neuropharmacology; 2017 Sep; 123():34-45. PubMed ID: 28504123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
    Rainville N; Jachimowicz E; Wojchowski DM
    Expert Opin Ther Targets; 2016; 20(3):287-301. PubMed ID: 26419263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF.
    Wang L; Chopp M; Gregg SR; Zhang RL; Teng H; Jiang A; Feng Y; Zhang ZG
    J Cereb Blood Flow Metab; 2008 Jul; 28(7):1361-8. PubMed ID: 18414495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia induces hemorrhagic transformation in pituitary adenomas via the HIF-1α signaling pathway.
    Xiao Z; Liu Q; Zhao B; Wu J; Lei T
    Oncol Rep; 2011 Dec; 26(6):1457-64. PubMed ID: 21822544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.
    Hardee ME; Cao Y; Fu P; Jiang X; Zhao Y; Rabbani ZN; Vujaskovic Z; Dewhirst MW; Arcasoy MO
    PLoS One; 2007 Jun; 2(6):e549. PubMed ID: 17579721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoietin Stimulates Tumor Growth via EphB4.
    Pradeep S; Huang J; Mora EM; Nick AM; Cho MS; Wu SY; Noh K; Pecot CV; Rupaimoole R; Stein MA; Brock S; Wen Y; Xiong C; Gharpure K; Hansen JM; Nagaraja AS; Previs RA; Vivas-Mejia P; Han HD; Hu W; Mangala LS; Zand B; Stagg LJ; Ladbury JE; Ozpolat B; Alpay SN; Nishimura M; Stone RL; Matsuo K; Armaiz-Peña GN; Dalton HJ; Danes C; Goodman B; Rodriguez-Aguayo C; Kruger C; Schneider A; Haghpeykar S; Jaladurgam P; Hung MC; Coleman RL; Liu J; Li C; Urbauer D; Lopez-Berestein G; Jackson DB; Sood AK
    Cancer Cell; 2015 Nov; 28(5):610-622. PubMed ID: 26481148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
    Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J
    Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SMND-309 promotes angiogenesis in human umbilical vein endothelial cells through activating erythropoietin receptor/STAT3/VEGF pathways.
    Du G; Zhu H; Yu P; Wang H; He J; Ye L; Fu F; Zhang J; Tian J
    Eur J Pharmacol; 2013 Jan; 700(1-3):173-80. PubMed ID: 23276662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
    Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
    Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation.
    Alvarez Arroyo MV; Castilla MA; González Pacheco FR; Tan D; Riesco A; Casado S; Caramelo C
    J Am Soc Nephrol; 1998 Nov; 9(11):1998-2004. PubMed ID: 9808085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
    Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
    Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cells.
    Belda-Iniesta C; Perona R; Carpeño Jde C; Cejas P; Casado E; Manguan-García C; Ibanez de Caceres I; Sanchez-Perez I; Andreu FB; Ferreira JA; Aguilera A; de la Peña J; Perez-Sánchez E; Madero R; Feliu J; Sereno M; González-Barón M
    Cancer Biol Ther; 2007 Oct; 6(10):1600-5. PubMed ID: 17938574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SMND-309, a novel derivative of salvianolic acid B, protects rat brains ischemia and reperfusion injury by targeting the JAK2/STAT3 pathway.
    Zhu H; Zou L; Tian J; Du G; Gao Y
    Eur J Pharmacol; 2013 Aug; 714(1-3):23-31. PubMed ID: 23764464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anacardic acid (6-pentadecylsalicylic acid) inhibits tumor angiogenesis by targeting Src/FAK/Rho GTPases signaling pathway.
    Wu Y; He L; Zhang L; Chen J; Yi Z; Zhang J; Liu M; Pang X
    J Pharmacol Exp Ther; 2011 Nov; 339(2):403-11. PubMed ID: 21828260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo.
    Miura O; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
    Blood; 1994 Sep; 84(5):1501-7. PubMed ID: 8068943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous erythropoietin and erythropoietin receptors in colorectal cancer; can we answer the questions?
    Čubranić A; Dobrila-Dintinjana R; Redžović A; Dintinjana M; Petranović D; Golčić M
    Med Hypotheses; 2016 Nov; 96():16-19. PubMed ID: 27959268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.